Teladoc Health (NYSE:TDOC) Earns “Hold” Rating from Needham & Company LLC

Needham & Company LLC reaffirmed their hold rating on shares of Teladoc Health (NYSE:TDOC) in a research report released on Thursday,Benzinga reports.

Other analysts have also issued reports about the stock. Bank of America lifted their price target on shares of Teladoc Health from $11.50 to $13.50 and gave the stock a “neutral” rating in a research note on Wednesday, February 12th. Piper Sandler reaffirmed an “overweight” rating and issued a $13.00 target price (up previously from $11.00) on shares of Teladoc Health in a research report on Wednesday, December 4th. TD Cowen lowered their price target on Teladoc Health from $9.00 to $8.00 and set a “hold” rating on the stock in a report on Thursday, October 31st. Deutsche Bank Aktiengesellschaft raised their price target on Teladoc Health from $10.00 to $12.00 and gave the stock a “hold” rating in a research note on Friday, November 1st. Finally, Barclays upped their price objective on Teladoc Health from $10.00 to $12.00 and gave the company an “overweight” rating in a research report on Thursday, October 31st. Eleven research analysts have rated the stock with a hold rating and seven have given a buy rating to the company. According to MarketBeat.com, the company has a consensus rating of “Hold” and a consensus price target of $11.44.

Teladoc Health Stock Performance

Shares of TDOC opened at $9.43 on Thursday. Teladoc Health has a 12 month low of $6.76 and a 12 month high of $15.95. The business’s fifty day simple moving average is $10.62 and its two-hundred day simple moving average is $9.53. The company has a current ratio of 1.73, a quick ratio of 1.69 and a debt-to-equity ratio of 0.66. The company has a market cap of $1.62 billion, a price-to-earnings ratio of -1.64 and a beta of 1.04.

Teladoc Health (NYSE:TDOC) last released its quarterly earnings data on Wednesday, February 26th. The health services provider reported ($0.28) EPS for the quarter, missing the consensus estimate of ($0.21) by ($0.07). Teladoc Health had a negative net margin of 37.91% and a negative return on equity of 10.06%. The business had revenue of $640.49 million for the quarter, compared to analysts’ expectations of $639.44 million. Research analysts anticipate that Teladoc Health will post -1.16 earnings per share for the current fiscal year.

Insider Buying and Selling at Teladoc Health

In other Teladoc Health news, insider Carlos Nueno sold 2,389 shares of the stock in a transaction on Monday, December 2nd. The stock was sold at an average price of $11.93, for a total value of $28,500.77. Following the completion of the sale, the insider now owns 2,890 shares in the company, valued at approximately $34,477.70. This represents a 45.25 % decrease in their position. The sale was disclosed in a filing with the SEC, which is accessible through the SEC website. Insiders own 0.95% of the company’s stock.

Hedge Funds Weigh In On Teladoc Health

Several large investors have recently made changes to their positions in the business. Creative Planning raised its stake in Teladoc Health by 184.7% during the 3rd quarter. Creative Planning now owns 64,125 shares of the health services provider’s stock valued at $589,000 after purchasing an additional 41,602 shares during the period. Blue Trust Inc. grew its holdings in Teladoc Health by 84.5% during the 3rd quarter. Blue Trust Inc. now owns 4,048 shares of the health services provider’s stock valued at $40,000 after buying an additional 1,854 shares in the last quarter. Private Advisor Group LLC grew its holdings in Teladoc Health by 26.9% during the 3rd quarter. Private Advisor Group LLC now owns 13,990 shares of the health services provider’s stock valued at $128,000 after buying an additional 2,962 shares in the last quarter. International Assets Investment Management LLC raised its position in shares of Teladoc Health by 693.0% during the third quarter. International Assets Investment Management LLC now owns 23,299 shares of the health services provider’s stock valued at $214,000 after buying an additional 20,361 shares during the last quarter. Finally, Wealth Enhancement Advisory Services LLC purchased a new position in shares of Teladoc Health in the third quarter worth $111,000. 76.82% of the stock is currently owned by hedge funds and other institutional investors.

Teladoc Health Company Profile

Teladoc Health, Inc provides virtual healthcare services worldwide. The company operates through Teladoc Health Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical, specialty medical, chronic condition management, and mental health, as well as enabling technologies and enterprise telehealth solutions for hospitals and health systems.